EMBO Molecular Medicine is an open access online journal published by Wiley-Blackwell on behalf of EMBO. The quality of the journal is guaranteed by the editorial and advisory boards, consisting of leading researchers in the field of molecular medicine, together with the commitment to scientific excellence and the professionalism of EMBO Editors.
Triple-negative breast cancer (TNBC) is difficult to treat due to its aggressive nature and resistance to chemotherapy. Exciting research published by the University of Southern Denmark sheds light on the mechanisms that ...
Apr 2, 2024
0
49
Chimeric antigen receptor T cells—CAR T cells for short—are immune cells (T cells) that are taken from the body and genetically modified outside the body in the laboratory using transport vehicles for the genes to be ...
Mar 22, 2024
0
0
Researchers at the University of Zurich and the University Hospital Zurich have discovered that a specific mutation in the cancer cells of an aggressive type of blood cancer can prevent novel immunotherapies such as CAR T-cell ...
Mar 21, 2024
0
23
Weizmann Institute scientists have discovered two small molecules that can cross the blood-brain barrier in mice, slowing and even reversing the effects of Huntington's, which is incurable.
Feb 26, 2024
0
40
A Brock-led international research team has discovered an immunotherapy method that could potentially add years to healthy aging. The research, published in the journal EMBO Molecular Medicine, introduces an innovative method ...
Nov 21, 2023
0
164
Researchers at the Center for Genomic Regulation and Vall d'Hebron Institute of Oncology have shown that the simultaneous inhibition of two different proteins may represent a new strategy for tackling triple-negative breast ...
Nov 8, 2023
0
0
A study spearheaded by Oregon State University has shown why certain polyunsaturated fatty acids work to combat a dangerous liver condition, opening a new avenue of drug research for a disease that currently has no FDA-approved ...
Oct 25, 2023
0
19
Infections with cytomegalovirus (CMV) are extremely common and often pose no major threat to the vast majority of people. They can however be deadly for people whose immune system is weakened, for example, after bone marrow ...
Oct 17, 2023
0
27
Currently, researchers from different institutions in the world are testing a drug against obesity and diabetes, and now a Danish led research team reports that the same substance has had a beneficial effect on mice with ...
Oct 11, 2023
0
1
Scientists have created a new zebrafish xenograft platform to screen for novel treatments for an aggressive brain tumor called glioblastoma, according to a new study published in EMBO Molecular Medicine.
Oct 4, 2023
0
30
